Infokiri
| Dokumendiregister | Terviseamet |
| Viit | 8.1-2/24/6738-1 |
| Registreeritud | 26.06.2024 |
| Sünkroonitud | 27.06.2024 |
| Liik | Sissetulev dokument |
| Funktsioon | 8.1 Nakkushaiguste seire, ennetuse ja tõrje korraldamine |
| Sari | 8.1-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus |
| Toimik | 8.1-2/2024 |
| Juurdepääsupiirang | Avalik |
| Juurdepääsupiirang | |
| Adressaat | ECDC respiratory viruses |
| Saabumis/saatmisviis | ECDC respiratory viruses |
| Vastutaja | Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond) |
| Originaal | Ava uues aknas |
Failid
|
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
To: Operational Contact Points for Influenza (microbiology)
Cc: National Focal Points for Viral Respiratory Diseases, National Coordinators
Dear Colleagues,
We intend to prepare a summary report of the influenza antigenic, genetic, and antiviral characterisation data with the available TESSy data. This report will be shared with the GISRS network and submitted to the WHO Consultation on the Composition of Influenza Virus Vaccines for use in the 2025 Southern Hemisphere Influenza Season which will take place 23-27 September 2024 (SH VCM).
The snapshot of the characterisation data reported to TESSy will be taken on 22 August (with upload of data latest by 10:00 am CET 22 Aug). Please upload the available data to TESSy in strain-based format in INFLANTIVIR record type, and the sequences that you have in GISAID EpiFlu database. Remember to release your sequences and use the Isolate ID, e.g. EPI_ISL_16494781, and report for haemagglutinin gene in HAISD variable to report to TESSy.
Please also report antiviral susceptibility data for oseltamivir, zanamivir and baloxavir.
Additionally, please ensure that the data for the 2023/24 season is complete, for the following record types and fields:
- INFLCLIN: intensity reporting
- INFLVIR or RESPIAGGR: sentinel and non-sentinel detections and test of influenza, RSV and SARS-CoV-2
- INFLSARIAGGR: detections and tests per age group and per pathogen
Please email [email protected] (for EU/EEA countries) or [email protected] (for countries outside EU/EEA), if you need assistance with data reporting.
Additionally, we would like to remind you to share specimens/isolates with a WHO Collaborating Centre by 14 August 2024. This will enable Collaborating Centres to have a good set of results ahead of the SH VCM.
The criteria for selection of specimens to send to a WHO CC are described in Operational Guidance for Sharing Seasonal Influenza Viruses with WHO Collaborating Centres available on the public WHO web site at: https://apps.who.int/iris/handle/10665/259400.
Best regards,
The ECDC and WHO Europe Influenza teams
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.
